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Abstract Until recently, the immune system was seen
solely as a defense system with its primary task being the
elimination of unwanted microbial invaders. Currently,
however, the functional significance of the immune system
has obtained a much wider perspective, to include among
others the maintenance and restoration of homeostasis
following tissue damage. In this latter aspect, there is a
growing interest in the identification of molecules involved,
such as the so-called danger or damage-associated molec-
ular patterns (DAMPs), also called alarmins. Since heat
shock proteins are archetypical molecules produced under
stressful conditions, such as tissue damage or inflammation,
they are frequently mentioned as prime examples of
DAMPs (Bianchi, J Leukoc Biol 81:1–5, 2007; Kono and
Rock, Nat Rev Immunol 8:279–289, 2008; Martin-Murphy
et al., Toxicol Lett 192:387–394, 2010). See for instance
also a recent review (Chen and Nunez, Science 298:1395–
1401, 2010). Contrary to this description, we recently
presented some of the arguments against a role of heat
shock protein as DAMPs (Broere et al., Nat Rev Immunol
11:565-c1, 2011). With this perspective and reflection
article, we hope to elaborate on this debate and provide
additional thoughts to further ignite this discussion on this
critical and evolving issue.
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What are DAMPs?
In the 1990s, Polly Matzinger introduced the concept of
immunological “danger” as a further refinement of
Burnet’s original clonal selection theory which is the
basis of self–nonself discrimination by the immune
system (Fuchs and Matzinger 1996). In her “danger”
concept of immune function, she proposed immune
responses result from detecting and addressing danger
and not just nonself. In this context, the molecules
associated with distress and damage (including self
molecules) are regarded as the prime stimuli for immuno-
logical reactivity.
Self-danger signals were postulated to originate from, for
instance, necrotic cells that succumb to infection or
ischemia. Subsequently, several molecules were ascribed
“danger”-associated molecule (DAMPs) functions, such as
high-mobility group box-1 (HMGB1) protein, the most
abundant member of the HMG family of DNA-binding
proteins. Other candidates include cytosolic calcium-
binding proteins of the S-100 family, nucleosomes, uric
acid, and antibacterial peptides (Harris and Raucci 2006). It
was logical and attractive to incorporate into this concept
families of heat shock proteins (HSPs) as they are
upregulated during stressful cellular events such as in tissue
necrosis. HSPs have since often been categorized as
prototypic “danger” associated molecular patterns or
DAMPs.
As a brief aside, the terminology in this field
exemplifies the continuing maturation of the danger
concept since its original inception. The term DAMPs is
given in analogy with the earlier coined PAMPs (pathogen-
associated molecular patterns), which were proposed to be
structures recognized by so-called pattern recognition recep-
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“damage”-associated molecular patterns. The latter was
proposed for the situation in clinical organ transplantation,
where the transplant does not reflect a danger but rather a
benefit to the recipient. The upregulated HSPs resulting from
reperfusion injury were therefore viewed as a typical DAMP
inthe sense of“damage” and not danger-associated molecular
pattern (Land 2005).
In the more narrow definition, DAMPs are intracellular
nonmicrobial molecules normally hidden from recognition
by the immune system. They are released during necrotic
and not apoptotic cell death, after which the innate immune
system responds both directly with inflammation and
indirectly by recruiting reinforcements from the adaptive
immune system (Kono and Rock 2008). Kono and Rock
have attempted to outline four criteria in terms of biological
outcomes that must be fulfilled for a molecule to be
classified as a DAMP (Kono and Rock 2008):
1. A DAMP should be active as a highly purified
molecule
2. The biological effect should not be owing to contam-
ination with microbial molecules. Caution is particu-
larly warranted if the putative DAMP is found to work
through receptors for PAMPs such as toll-like receptors
(TLRs).
3. The DAMP should be active at concentrations present
in pathophysiological situations
4. Selective elimination or inactivation of the DAMP
should ideally inhibit the biological activity of dead
cells in in vitro or in vivo assays.
In the case of HSPs, the first two criteria are already
problematic. Given their chaperone nature, HSPs readily
engage other molecular structures, and experience has
taught us that recombinant HSPs are easily contaminated
with microbial products when produced in microbial
expression systems. Criterion 4, by the authors’ own
admission, is an ideal effect, and in most cases, this
criterion is not fulfilled. To put it bluntly, it seems
questionable whether or not there exists any single DAMP
which meets all of these criteria. Our brief analysis of the
current literature on DAMPs suggested that convincing
evidence for single DAMP molecules initiating pro-
inflammatory responses, as proven by the above criteria,
may be lacking so far.
Microbial HSPs are immunodominant and induce
cross-reactivity with self-HSP
One of the remarkable characteristics of HSPs is their
immunodominance. HSP60 was already known as the
“common antigen” of gram-negative bacteria before the
actual recognition of its molecular identity. Immunization
with gram-negative bacteria led to the production of high
levels of antibodies specific for this common antigen
(Thole et al. 1988). Since the mycobacterial HSP60
molecule was cloned (Thole et al. 1985), Kaufmann and
others have performed immunization studies with myco-
bacteria and with recombinant mycobacterial HSP60
demonstrating the resulting frequency of HSP60-specific
T cells can be very high. After immunization with
Mycobacterium tuberculosis, approximately one out of five
of the M. tuberculosis-reactive T cells recognizes HSP60.
Immunization with recombinant HSP60 in an adjuvant also
stimulated an impressively high number of M. tuberculosis-
reactive T cells (1 out of 2,000) (Kaufmann et al. 1987).
Since then, many others have shown the dominant immuno-
genicity of microbial HSPs (Zugel and Kaufmann 1999).
Given the conserved nature of HSPs, this high level of
immunogenicity is not immediately understood. One would
predict a low degree of immunogenicity for molecules
having extensive sequence similarities with self antigens. A
healthy immune system is not supposed to respond to self
antigens or their closely related homologs. Paradoxically,
when mapping T cell epitopes for mycobacterial HSP60 in
Lewis rats, defined epitopes included many conserved
sequences, and the responding T cells were found to cross-
respond tohomologousself-peptide derived frommammalian
HSP60 (Anderton et al. 1995). Since then, self-HSP cross-
reactive T cells have been identified in many models and
even in human cord blood (Durai et al. 2004;P a u le ta l .
2000). In children suffering from juvenile idiopathic arthritis,
their strongest T cell responses to self-HSP60 were detected
in patients during remitting phases of their disease, sugges-
tive of an anti-inflammatory mechanism resulting from self-
HSP-directed T cell reactivity (de Graeff-Meeder et al. 1995;
de Kleer et al. 2003; Prakken et al. 1996).
Furthermore, autoantibodies against HSP have been
found to be prevalent in healthy subjects. For HSP60, this
was summarized by Quintana and Cohen (2011). Similar
patterns of autoantibodies are observed for self-HSP70,
for example in diabetes and atherosclerosis (Abulafia-
Lapid et al. 2003). Interestingly, antigen microarray
analysis for multiple sclerosis (MS) patients revealed that
HSP70 autoantibodies were a characteristic antibody
signature of patients with a remitting and relapsing form
of the disease. These antibodies were much less abundant
in patients with progressive forms of MS, again associat-
ing HSP70 immune reactivity with disease remission
(Quintana et al. 2008).
The immunodominance of HSPs may not depend
on interactions with innate receptors
There are no reports of peculiar pro-inflammatory isotype
(e.g., IgG2a) profiles for HSP-binding antibodies in patients
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polyclonal stimulation of mouse B cells with human
HSP60 induced production of IgG3. These activated B
cells were also found to stimulate a Th0 profile in T cells as
opposed to a typical Th1, as indicated by their production
of interleukin (IL)-10 and interferon gamma (INF-γ;
Cohen-Sfady et al. 2005). In addition, T cells reactive to
HSPs that have been reported were typically not pro-
inflammatory, regardless of whether they were stimulated
with mammalian (self) HSP or microbial HSPs. In stark
contrast, many antibodies or responding T cells were found
to have anti-inflammatory activities (Moudgil et al. 1997;
Ulmansky et al. 2002; van Eden et al. 2005). These were
demonstrated by their abilities to suppress an inflammatory
disease or to produce anti-inflammatory cytokines such as
IL-10 (Prakken et al. 2001). In other words, despite the fact
that responses to HSPs may be of fundamental interest to
the immune system, the phenotypic characteristic of HSP
immune reactivity does not reflect a typical DAMP-
associated pro-inflammatory response.
Be that as it may, one cannot exclude that the dominant
immunogenicity of HSP stems from their interaction with
TLRs or other innate receptors. However, there remain
other possibilities which may explain the potent immuno-
genicity of HSPs equally well (Table 1). Firstly, the more
practical explanation is exposure. The immune system is in
continuous contact with conserved microbial HSPs. The
symbiotic relationship between the gut and intestinal
microbiota ensures the regular immunological surveillance
of our resident flora. Be it benign colonization by
commensals or true invasion by pathogens, it will impose
stress on every intruder, which will lead to an upregulation
of microbial HSP and provide ample and repetitive
opportunity for our immune system to respond to HSP.
And logically, the immune response would most frequently
encounter the most conserved epitopes. In this response, the
expansion of T cells specific for conserved epitopes
increases the likelihood of cross-reactivity with self-HSP.
Secondly, given their chaperone activities, an alternative
explanation is that HSPs are hitchhiking with other antigens
for uptake and processing by antigen-presenting cells. In
this manner, they may frequent the priority lane in the
antigen processing system. A third possibility is that HSPs
have an organized priority status for the immune system.
Cohen has argued that HSPs are examples of immune-
privileged antigens, so-called homunculus antigens. This
would imply that the reactivity to such molecules is a
genetically determined inherent quality of the immune
system (Cohen 2007). Thus, there are more ways to explain
the exceptional immunogenicity of HSP, which do not
depend on immediate interaction with TLRs or other
receptors of the innate immune system. In conclusion,
although the high immunogenicity may suggest innate
receptors to be involved, there are ample alternative options
to explain this aspect of HSP.
A primary feature of chaperones is their capacity to bind
peptides. HSP70 has peptide-binding domains for exposed
hydrophobic residues of substrate proteins. When peptide-
loaded HSP70 is delivered to dendritic cells (DCs), the
peptide is rerouted through the major histocompatibility
complex (MHC) class I pathway antigen presentation, via
cross-presentation, for display to CD8
+ cytotoxic T cells
(Rock and Shen 2005). In a number of studies on cross-
presentation by HSP, evidence was provided for a stimula-
tory effect on DC maturation and activation (Binder 2009).
With respect to accompanying DC maturation, controversy
has arisen regarding the role of microbial contaminants in
this DC stimulatory effect as some authors have presented
evidence that lipopolysaccharide (LPS; TLR4), lipoprotein
(TLR2), or flagellin (TLR5) were the active compounds
here (Tsan and Gao 2009). In one study, purposeful
removal of contaminating LPS did not prevent peptide
presentation, but did abrogate activation of human DCs in
association with human HSP70 (Bausinger et al. 2002). In
juxtaposition, peptides fused to HSP60 also induced CD8
+
cytotoxic T cells (Cho et al. 2000). This fusion product was
stimulatory to DCs, leading to upregulation of MHC (class
I and II) and co-stimulatory molecules (B7.2), whereas
unexpectedly HSP60 alone was not stimulatory. Again, this
led to a suspected role of contaminants in the fusion
proteins. Thus, although cross-presentation mediated by
HSP seems real, the DC stimulating activities may be
uncertain, to say the least. A balanced review which,
overall, argues against endotoxin being the “active”
ingredient in many HSP effects is however Henderson
et al. (2010).
The difficulty of the “one molecule–one receptor–one
functional response” idea
DAMPs are generally regarded as being intracellular
proteins that are hidden from recognition by the immune
system until exposed by cell damage, such as necrosis.
Presumably, this release of DAMPs into the extracellular
fluid begins an inflammatory response. Several receptors
are purported to mediate DAMP recognition (e.g., receptor
for advanced glycation end products (RAGE) and TLR9)
and subsequently propagate an inflammatory response.
Table 1 Mechanisms leading to the HSP immunodominance
Repeated contact leads to a focus on conserved regions
Hitchhiking in the antigen uptake and processing machinery
Built-in feature of the immune system (homunculus idea)
Triggering of innate TLR receptors?
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proposed to be mediated through receptor-mediated endo-
cytosis (Arnold-Schild et al. 1999). In the latter case TLRs,
such as TLR2 and 4, are again implicated as the dominating
receptors (Vabulas et al. 2001).
There is now a general consensus that the interactions of
TLRs with PAMPs evolved to prepare the immune system
for tailor-made responses to invading microbes. A diversity
of TLRs (and also RIGS, NOD, etc.) enables the immune
system to be discriminative at the early level of innate
defenses. A microbe that activates TLR4 and TLR5 is likely
to be a flagellated gram-negative bacterium, while a microbe
that triggers TLR2, 5, and 6 qualifies to be a flagellated gram-
positive bacterium. Very aptly, this was called the barcode
model of immune recognition (Aderem 2003). However, this
concept raises several questions with regard to HSPs. Which
advantageous aspect would HSPs serving as DAMPs offer to
this system? What would have been the evolutionary
advantage of having HSP as a DAMP included in such a
recognition strategy? A direct innate response to proteins
released by necrotic cells, unidirectionally activating a pro-
inflammatory response, would disturb the “bar coding”
mediated through TLR and other innate receptors. A feature
of TLRs which still remains to be fully appreciated is that
they generate not only pro-inflammatory responses but also
suppressive responses in innate immune cells (Conroy et al.
2008). TLR2 for example has been shown to be present on
Treg cells, and its triggering by an HSP60-derived peptide
led to cytokine and contact-dependent suppression
(Zanin-Zhorov et al. 2006). Also, TLR2 triggering by
Pam3Cys led to Treg induction (Sutmuller et al. 2006). In
addition, IL-10-producing T cells were generated in vivo
through TLR2 triggering by capsular polysaccharides of
commensal bacteria (Round and Mazmanian 2010). TLR4
triggering by LPS was seen to enhance survival and
proliferation of Treg cells (Caramalho et al. 2003). This
means thatthesereceptorshavenodanger conveyingpower on
their own. The effectoftheir triggering is therefore mostlikely
cell-type specific and may depend very much on the context of
their triggering, other factors released by other cells in the
vicinity, and other receptors triggered simultaneously. In other
words,theintegrationofmultiplesignalsmustfinallyconverge
within a particular cell to drive the biological outcome. Given
the examples of suppressive effects by HSP-derived peptides
inthiscontext,itseemsevenpossiblethatHSPsaredampening
inflammatory signals through these innate receptors.
The search for dedicated heat shock protein receptors has
been intensive over the past years. We are left with a broad
array of receptors with rather promiscuous binding charac-
teristics. Of the scavenger receptors, heat shock proteins are
now known to interact with SRA-1, SREC-1, LOX-1, and
FEEL-1 (Calderwood et al. 2007). Interestingly, some of
these receptors were found to be immunosuppressive, such
as SRA-1 (Wang et al. 2007). As put forth by Calderwood:
“Discerning the signaling networks emanating from such an
array of receptors will be challenging; however, this is
essential if sense is to be made of the heat shock protein
signal input” (reported in (Henderson et al. 2010).
Whatever the outcome of such an exploration will be, a
simply straightforward monotonous pro-inflammatory HSP
response will be an unlikely outcome. It is the result of
modern cellular and molecular technologies that we tend to
study single types of cells in their interactions with single
defined molecules through tentative single receptors.
However, in reality, the complexity of immune behavior
will not be visible by analyzing a linear sequence of
consecutive events from cause to effect. We will need a
systems biology approach to integrate responses to HSP
into a context-dependent unified systemic response.
DAMP disqualifying features of HSP
Avariety of molecules have been nominated to trigger innate
receptors in a pro-inflammatory manner. They are often
presented as putative DAMPs, despite the fact there may be
no discernable patterns associated with their molecular
structures. However, this is generally accepted as the name
DAMP was coined in keeping with the PAMPs analogy of
which the classical examples exhibit obvious molecular
patterns. Yet, HSPs are not known to harbor any molecular
patterns or to have any sequence or structural similarities
between HSP of different families. Possibly with an excep-
tion, if we accept the suggestion of hydrophobicity as a
damage-associated molecular pattern. In that case, HSP may
have hydrophobic binding sites that are exposed in an ATP-
dependent manner to allow binding to hydrophobic parts of
nascent or unfolded proteins (Seong and Matzinger 2004).
Possibly of more relevance to our discussion is the fact that
there are no systematic differences between self and
microbial HSP. Therefore, the immune system does not
seem to possess receptors that may distinguish the self from
microbial. As a consequence, if self-HSPs were DAMPs, one
would also expect the immunodominant microbial HSPs to
exert a continuous pro-inflammatory effect in our immune
system: an unlikely and not very attractive situation.
DAMPs typically reside intracellularly and are only
exposed to the extracellular environment when cells
undergo necrosis. However, HSPs are also exposed at the
cell surface (Multhoff 2007) and exist as freely circulating
HSP (Pockley and Multhoff 2008), and neither of these
forms are easily compatible with DAMP-type pro-
inflammatory activities of HSP.
Some DAMPs are claimed to exert their effects via a
receptor associated with pro-inflammatory signaling. This
is the case given for HMBG-1 and RAGE. Antibody
blocking of RAGE was seen to inhibit the ability of
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that RAGE binds a pro-inflammatory HMBG-1 (Luan et al.
2010). However, despite the fact that HMBG-1 may be
taken as a prototypic DAMP, its role in directly promoting
inflammation is also clouded in controversy (Bianchi
2007). In fact, the discussions here are similar to those
concerning HSPs as HMBG-1 can also complex with other
molecules such as LPS, and these associations are incrim-
inated as the possible sources of the pro-inflammatory
stimuli. Highly purified recombinant HMGB-1 was demon-
strated tohavea veryweak directpro-inflammatory activityat
best(Rouhiainen etal. 2007). To quote another paper: “Thus,
for full activity, HMGB1 may need to form a complex with
another component to activate inflammation by enhancing
effects stimulated by a PAMP, a DAMP, or a pro-
inflammatory cytokine. Importantly, HMGB1 can bind avidly
to immuno-stimulatory molecules such as LPS, DNA, or
interleukin (IL)-1β and promote their activity in a synergistic
fashion” (Pisetsky et al. 2008).
As mentioned, no specific or unique receptors are known
for HSPs. And the most credited TLR receptors are not
strictly pro-inflammatory. Interestingly, TLR2 and TLR4,
which are possibly the primary receptors for HSP60 and
HSP70, were found not to be essential in the host response
to DAMPs derived from necrotic cells (Chen and Nunez
2010). Most relevant in this discussion are the results of
experiments in which DCs were cultured in the presence of
HSPs. For self-HSP, there is a lack of compelling evidence
that HSP can directly activate dendritic cells, which are
expected to express the whole panoply of DAMP receptors.
When exorbitant concentrations (200–300 μg/ml) of self-
HSP70 (purified from mouse liver using standard protocols
under sterile conditions and with endotoxin-free reagents)
were applied, no stimulatory effects on murine DCs were
observed (Wallin et al. 2002). As an aside, the same authors
have seen responses to low concentrations (50–100 ng/ml)
of the same liver-derived HSP70 contaminated with minute
amounts of endotoxin. Given the role of dendritic cells as
key initiators of the immune response and their ability to
give direction to the ensuing adaptive response, one may
wish to see full activation of DCs for a pro-inflammatory
adaptive immune response reaction. In even more careful
analyses, human HSP70 has shown a lack of direct human
DC activation qualities (Bendz et al. 2008). Despite earlier
claims (Floto et al. 2006), even mycobacterial HSP70
exhibited an absence of activation (no calcium signaling) of
human DCs (Bendz et al. 2008). And possibly more telling,
the group of Bonorino has shown that highly purified
mycobacterial HSP70 impaired the maturation of murine
bone marrow-derived DCs, leading to inhibition of T cell
proliferation (Motta et al. 2007). Finally, HSPs seem to
exert immune-dampening effects in model systems, as we
will discuss in the following section (Table 2).
The immune-“dampening” activity of HSP
Initial studies of the immunological effect of HSP were
carried out with recombinant mycobacterial HSP60 in the
rat model of adjuvant arthritis. HSP60 immunizations were
found to inhibit disease development in this Tcell-mediated
autoimmune disease model (van Eden et al. 1988). This
disease ameliorative effect was T cell mediated since
transfer of HSP60-specific T cells into naïve recipients also
imparted protection against arthritis in the recipients. By
analyzing the exact antigen specificity of the protective T
cells, it was discovered that disease suppression was
mediated by T cells that responded to a particularly
conserved HSP60 sequence. This sequence was so con-
served that these T cells cross-recognized the homologous
sequence present in the mammalian HSP60 molecule.
Immunization with a synthetic peptide comprising this
protective T cell epitope induced a fully protective T cell
response against arthritis (Anderton et al. 1995). Cytokine
analyses of the protective T cells demonstrated their
capacity to produce suppressive cytokines such as IL-10
(Prakken et al. 2001). Since then, similar protective effects
have been shown for microbial HSPs, including members
of the HSP70 family, in various experimental models of
autoimmunity (summarized in (van Eden et al. 2005).
A recent study by Borges et al. further demonstrated the
immunosuppressive potential of mycobacterial HSP70 in two
allograft survival models, an allogeneic melanoma and a
regular allogeneic skin graft. Very interestingly, rejection was
inhibited by HSP70 incubation of the melanoma cells or the
skin prior to grafting. Concurrent injection of an anti-
CD25 antibody removed Treg cells and fully abolished
the rejection inhibitory effect (Borges et al. 2010).
Altogether, astonishing findings for a molecule derived
from a microbe—mycobacterium—which is known to have
such strong immune-potentiating effects!
In some studies, immunizations with mammalian HSP
have also been shown to inhibit disease. This was done in
arthritis for HSP60 (Paul et al. 2000)a n dH S P 7 0
(Chandawarkar et al. 2004; Corrigall et al. 2001; Wendling
et al. 2000) and in diabetes with an HSP60-derived peptide
(Bockova et al. 1997). In in vitro studies, Gp96 (glucose-
regulated protein 94), a member of the HSP90 family of
Table 2 Features of HSPs which disqualify them as DAMPs
Absence of molecular patterns
Main receptors TLR2 and TLR4 are not always pro-inflammatory
TLR2 and TLR4 are not needed for signaling by DAMPs from
necrotic cells
Some HSP receptors are downregulating inflammatory signaling
HSP-incubated DCs adopt a tolerogenic phenotype
HSP immunizations are anti-inflammatory
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derived dendritic cells, but at a higher dose led to an
increased IL-10/INF-γ ratio in T cells. This skewing also
indicated the induction of a regulatory mode in T cells and
was shown to induce a state of T cell hyporesponsiveness
and delay the rejection of cardiac allografts in rats
(Mirza et al. 2006; Slack et al. 2007).
More recently, we have shown that endogenous upregu-
lation of HSP by HSP co-inducing compounds may also
lead to the induction of HSP-specific Treg cells. In the
mouse model of proteoglycan-induced arthritis, we have
shown that oral administration of oregano-derived carvacrol
led to the upregulation of HSP70 in gut Peyer’s patches and
draining lymph nodes and to the suppression of disease
development. Also, T cells were found to exhibit elevated
HSP70-specific recall responses. Moreover, the T cells
responding to oral carvacrol treatment were shown to be
CD4
+CD25
+Foxp3
+ in the spleen and in the joint,
indicating that the disease suppression was mediated by
the induction of genuine Treg cells (Wieten et al. 2010). A
similar effect may have occurred in the case of triptolide-
induced HSP70 expression, which may have yielded the
protective effect in EAE models for multiple sclerosis
(van Eden 2009).
Genetic evidence for a disease suppressive role of
endogenous HSP70 was obtained in a transgenic mouse
model of dextran sulfate sodium-induced colitis. Reduced
disease and less pro-inflammatory cytokine production
were seen in HSP70-overexpressing animals. In HSF-1
null mice, the opposite phenotype was observed, as disease
worsened and more pro-inflammatory cytokines were
produced (Tanaka et al. 2007). A similar study showed
the disease suppressive role of HSP70 in bleomycin-
induced pulmonary fibrosis (Tanaka et al. 2010).
Recently, Shields et al. introduced the idea of certain
HSP molecules acting as “resolution-associated molecular
patterns” or RAMPs. RAMPs were proposed to exert
immunological activity by restoring immune homeostasis
by deactivating cells of the innate immune system and by
expanding regulatory cells (Shields et al. 2011). While they
accept the idea that most HSP will act as DAMPs, they
propose some HSP molecules (HSP10, HSP27, alpha B-
crystallin, and BiP or GRP78) to be exceptional and to act
as RAMPs. In our opinion, the examples they cite have
effects similar to those seen for members of major HSP
families such as HSP60 and HSP70. HSP10 was formerly
known as the early pregnancy factor and had an immune
regulatory role in preventing of rejection of the allogeneic
embryo. Since then, HSP10 was found to have immune
regulatory effects in various other systems: serum levels were
found to correlate with T cell receptor down-modulation
(CD3ζ expression), proliferation of Jurkat T cell lines was
inhibited, and in vitro, HSP10 pretreatment inhibited LPS-
stimulated TNF-α and IL-6 secretion by human peripheral
blood mononuclear cells (Johnson et al. 2005).
Recombinant HSP27 has a tendency to induce IL-10
secretion in cultured human monocytes, and it blocks
differentiation of monocytes to dendritic cells (De et al.
2000; Laudanski et al. 2007). In monocytes, the HSP70
family member BiP was found to downregulate MHC and
the co-stimulatory molecule CD86. Instead, it stimulated
production of anti-inflammatory cytokines IL-1 receptor
antagonist, soluble TNF receptor II, and IL-10 (Corrigall
et al. 2004).
Additional immunosuppressive effects of HSP have also
been seen in the case of exosome-associated HSP70.
Membrane-associated HSP72 obtained from tumor-derived
exosomes were observed to mediate a suppressive activity
in myeloid-derived suppressor cells. Possibly, this is one
mechanism by which tumor immune surveillance is
restrained (Chalmin et al. 2010). The possible further
complexity of HSP-associated cellular export vesicles and
cellular communications under stress conditions and its
potential implications have already been discussed in an
authoritative manner by de Maio in an earlier perspective
and reflection article (De Maio 2011).
HSP and immune homeostasis
If we refute the possibility that HSP are DAMPs, and we
recognize the prominent role of HSP in cognate interactions
with the immune system, we are confronted with the
question of what the actual immunological significance of
HSP may be. The elevated levels of HSP in inflamed,
traumatized, or reperfused tissues in combination with the
extensive immune repertoire of cells with the capacity to
recognize HSP indicate that these proteins may be
biomarkers of damage, providing targets for immune
mechanisms involved in restoration of tissue and immune
homeostasis.
With the recent rediscovery of regulatory T cells (Treg),
the role of the immune system in homeostasis has received
renewed interest. Also the reinterpretation of self/nonself
discrimination, as was revamped by the “danger” concept,
seems to have boosted our appreciation of mechanisms of
immune homeostasis.
Currently, there is a flurry of interest in the host–microbe
interrelationships at the level of the gut microbiota. The
immune system cannot tolerate becoming rampantly stim-
ulated by foreign molecules, but has to figure out whether a
certain stimulus is just microbial nonself or a signal of
imminent danger. In the case of benign microbial nonself as
present in our enteric microbiota, a carefully regulated
response suffices or is even imperative. It is in this
relationship that a major role for Treg cells is proposed.
Despite many technical obstacles, it is now widely accepted
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in an antigen-specific manner, also in areas other than the
gut. There are two functional categories of Treg cells.
Natural Treg cells are represented by a specialized subset of
CD4
+DC25
+Foxp3
+ T cells that are selected in the thymus
on the basis of relatively high affinity self-recognition. The
second group is inducible Treg cells. These CD4
+ T cells,
which are also mostly CD25
+Foxp3
+, are programmed in
the peripheral lymphoid organs or in the tissues to adopt a
regulatory status. Notably, HSPs are abundantly expressed
in the thymus in the areas where positive selection of T
cells takes place (Anderson et al. 2002). Therefore, HSP-
specific natural Treg cells may be selected in the thymus,
whereas HSP-specific induced Treg cells may originate
from elevated HSP expression in stressed peripheral tissues.
Besides their prominent role in the maintenance of
immune homeostasis in relation to symbiotic interactions
with the gut microbiota, Treg cells are implicated in the
anti-inflammatory responses that are seen in autoimmunity,
cancer, and infection (Vignali et al. 2008). During infection,
Treg cells help to resolve the pro-inflammatory response,
thereby reducing bystander damage. In addition, Treg cells
may be even more fundamental in the organization of the
immune response. For example, it has been shown that Treg
cells may function to aid in efficient cell entry into sites of
infection (Lund et al. 2008).
On the basis of the findings in experimental animal
models, new evidence seems to have surfaced that HSP can
be antigens that stimulate the activity of Treg cells (see also
previous section). For several reasons, this latter possibility
may be plausible and attractive.
Every cell in the body harbors the full spectrum of HSP
molecules. Under stress, many of them are upregulated, and
their fragments are processed and presented by MHC
molecules on the cell surface. HSP70 may have a
preferential position here. Some HSP70 family members
(Hsc70 or HSPA8 and in addition DNAJB1 and HSPC) are
involved in chaperone-mediated autophagy, a process
whereby during stress or nutrient deprivation cytosolic
proteins are reused by cells and are routed through a
subcellular compartment that intersects with the MHC class
II route (Majeski and Fred Dice 2004). This means that,
especially under stress, fragments of HSP70 may be loaded
into MHC class II products. Herewith HSP70 epitopes are
being presented in a preferential manner to CD4
+ T cells,
which includes Tregs. Based on other arguments, such as
the autophagy-mediated disposition of proteins with a long
half-life and MHC binding predictions, HSP70 has already
been proposed as an important source of peptides to be
loaded onto MHC class II molecules, also in the absence of
stress (Paludan et al. 2005). A mass spectroscopy analysis
of peptides eluted from MHC class II obtained from
stressed human B cells, revealed that HSP70 (HSPA1A,
HSPA6, and HSPA8) fragments composed a major portion
of the bound collection of peptides (Dengjel et al. 2005).
Thus, the immune system, including Treg cells, has ample
opportunity to encounter MHC-presented HSP epitopes,
and this will be especially prevalent during inflammation or
other stress conditions.
For Treg cell-mediated immune homeostasis this situa-
tion may be ideal. When trying to imagine how antigen-
specific Treg cells could work, one has to realize that it is
unlikely that effective regulation is secondary to the
presence of a very small number of autoantigen-specific
Treg cells present in a polyclonal population. As already
pointed out by Shevach, a more likely scenario is that
polyclonal Treg cells are able to exert control because they
are being regularly activated through their TCR by
complexes of MHC class II and ubiquitous self-peptides
(Shevach 2009). If so, HSPs would provide an excellent
collectionofprominentlyexpressed—certainlyunderstress—
ubiquitous self antigens. This qualifies them very well as
targets for Tcell regulation.
HSPs are further implicated in many situations where host
immune homeostasis is challenged. Figure 1 represents three
typical scenarios: sterile tissue damage (autoimmune inflam-
mation,reperfusioninjury,heatstress),truedangerimposedby
pathogen invasion (infection), and commensalism/symbiosis
(e.g., exposure to gut microbiota). Maintenance of tissue
homeostasis is required in all these instances, and one may
assume that the immune system is having a major role here.
This may well include the responses of the immune system to
HSP. Given the postulated capacity of HSPs to trigger Treg
cells, it seems attractive to attribute, at least in part, the
restoration of tissue and immune homeostasis to the activity of
HSP-specific Treg cells.
Extracellular versus intracellular HSP
There exist two ways by which heat shock proteins can
interact with the immune system (Fig. 2). First of all, their
intracellular upregulation as a consequence of cell stress
will lead to upregulated MHC presentation of HSP frag-
ments (peptides) at the cell surface making them visible to
T cells. Secondly, they may be translocated by yet
undefined mechanisms, as complete molecules to the cell
surface or to the extracellular environment. This would
allow them to be encountered by NK cells, antibodies, and
antigen-presenting cells. Besides active translocation, cell
necrosis is probably a mechanism through which HSPs are
released into the extracellular environment. It is safe to
conclude that these two distinct contexts for HSP interactions
with the immune system will lead to distinct immunological
outcomes.
In principle, DAMP producing cell death is proposed to
result mainly from necrosis. Whether cell death is immu-
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central issues in immunology. There is ample evidence that
apoptosis is non-immunogenic. However, the activation
state of dying cells seems relevant (Green et al. 2009).
Activated apoptotic cells have adjuvant properties and
induce expression of maturation markers (CD80, CD83,
and CD86) and secretion of pro-inflammatory cytokines in
DCs (Johansson et al. 2007). In contrast to this, T cells that
succumb to activation-induced cell death after clonal
expansion promote tolerance by stimulating regulatory
CD8
+ T cells (Herndon et al. 2005). Thus, timing of cell
death seems important: cell death at the peak of the immune
response produces immune activation, whereas cell death
during a waning immune response supports regulation.
Most necrotic cells are considered to produce an immune
response, but also here the cell type, the history of the cell,
its mode of activation, and the manner of stress imposed on
the cell may determine whether or not this form of cell
death is immunogenic (Green et al. 2009). In other words,
as long as we do not know exactly how to correlate the
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Fig. 1 The immune system will
restore homeostasis when the
latter is challenged by sterile
damage, pathogens, or com-
mensals. In all cases, HSPs are
present and even upregulated
host responses are terminated by
regulation. In the host response,
the HSP can be the targets
for the regulation, such as for
the regulation exerted by
Treg cells
Control of inflammation
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Fig. 2 Extracellular HSPs are
released from necrotic cells
when cells die from infection.
The released HSP will be seen
by receptors on antigen-
presenting cells such as DC in
combination with PAMPs. It
is possible that HSPs do
contribute to the PAMP-elicited
inflammatory response,
thereby enhancing collateral
tissue damage. Sterile inflam-
mation will upregulate intracel-
lular HSP in antigen-presenting
cells such as DC which leads
to the triggering of regulatory T
cells that dampen inflammation
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death, it will be hard to fully grasp the immunological role
of HSP in cell death.
One of the problems that is associated with the
immunogenicity of cell death is that cell death due to
infection needs to be immunogenic, at least to some extent.
When dying cells would provide antigens, let us say HSP,
that would lead to a firm tolerance or suppressive
regulation, such tolerance or suppressive regulation would
possibly include the microbial invader that led to cell death.
This scenario is incompatible with effective antimicrobial
defense. The alternative possibility is that DAMPs of dying
cells would always promote immune responses. This is also
problematic since this would convey the risk of autoimmu-
nity. Again, given the complexity of cell death immunoge-
nicity, there may not be a simple one-dimensional role in
cell death for HSP.
In the case of cell death due to infection, PAMPs may
have an overriding effect driving a pro-inflammatory
response, at least at the start of infection. One cannot
exclude that extracellular HSPs contribute a positive pro-
inflammatory effect of PAMP-activated cells, such as
activated DCs by possibly amplifying their TLR signaling.
It is also possible that HSPs form complexes with PAMPs
to support pro-inflammatory activity by chaperoning the
PAMPs involved or by synergistic effects. A similar
discussion has been active with respect to HMGB-1. It
was proposed that HMGB-1 released in the presence of
TLR-binding PAMPs acted to promote inflammation,
whereas HMGB-1 released in an environment devoid of
PAMPs promoted tissue repair (Harris and Raucci 2006). If
this were the case, then it seems reasonable to assume a
similar situation for HSP.
Necrosis resulting from infection will lead to a pro-
inflammatory response based on recognition of both
PAMPs/DAMPs and possibly HSPs. The ensuing elimina-
tion of the invaders would coincide with collateral damage.
At this point, regulation in the form of active resolution, in
part based on HSP recognizing Treg cell, would kick-in and
contribute to restoration of tissue homeostasis. From
another point, intracellular HSP would, besides their main
task in safeguarding against intracellular protein misfolding
under stress, find its way to the cell surface in the context of
MHC molecules and trigger a presumably regulatory
response at the level of T cells.
In addition, there may be still be the somewhat
theoretical issue of active concentrations of HSP. At low,
more or less constitutive concentrations, HSP may help to
maintain immune homeostasis by promoting Treg cell
activities. However, it is theoretically possible that relative-
ly high concentrations of HSP that are liberated at sites of
tissue damage or infection cause a loss of regulatory
capacity and contribute to pro-inflammatory responses.
This would imply that when cellular stress decreases,
resolution would set in and Treg cells would become
prominent responders when local HSP concentrations fall
(Quintana and Cohen 2011).
Irrespective of possible pro-inflammatory effects of
supra-constitutive concentrations of HSP, under physiolog-
ical conditions, a dampening effect on the immune system
would prevail. Mounting experimental findings seem to
support the latter supposition. HSP can therefore be called
DAMPERs rather than DAMPs. This may be very much in
line with the recent successful clinical interventions in
autoimmune inflammatory diseases based on the adminis-
tration of HSP peptides (Albani et al. 2011; Fischer et al.
2010; van Eden et al. 2010).
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